Eribulin use in MBC (Metastatic breast cancer) in resource limited setting

被引：0
|
作者：
Roy, Rakesh [1 ]
Sarkar, Abhijit [1 ]
机构：
[1] Saroj Gupta Canc Ctr & Res Inst, Med Oncol Dept, Kolkata, India
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
10.1093/annonc/mdz343.115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3 - 104
引用
收藏
页数：1
相关论文
共 50 条
  • [31] FINANCIAL DISTRESS IN METASTATIC BREAST CANCER (MBC).
    Rosenzweig, Margaret
    West, B. Marlene
    Berube, Roseanne
    Matthews, Jennifer
    Stokan, Melina
    ONCOLOGY NURSING FORUM, 2017, 44 (02)
  • [32] Interim safety results of eribulin (E) combined with ramucirumab (RAM) in patients (pts) with advanced metastatic breast cancer (MBC)
    Yardley, Denise Aysel
    Osborne, Cynthia R. C.
    Richards, Paul D.
    Daniel, Brooke R.
    Danso, Michael A.
    Favret, Anne
    Bromund, Jane
    Hsu, Yanzhi
    Ibrahim, Ayman B.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (27)
  • [33] Quality of care for metastatic breast cancer (MBC)
    Luis, Ines Vaz
    Lin, Nancy U.
    Freedman, Rachel A.
    Barry, William Thomas
    Winer, Eric P.
    Hassett, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [34] Utilisation and Outcomes of Eribulin in Triple-Negative Metastatic Breast Cancer (TN MBC): Real-World Findings
    Kish, Jonathan K.
    Mougalian, Sarah S.
    Copher, Ronda
    McAllister, Lindsay
    Wang, Zhixiao
    Janevski, Mile
    Broscious, Mary
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 123 - 123
  • [35] Efficacy it eribulin in patients (pts) with metastatic breast cancer (MBC): A pooled Analysis by HER2 and ER status
    Kaufman, Peter
    Twelves, Chris
    Cortes, Javier
    Vandat, Linda T.
    Olivo, Martin
    He, Yi
    Awada, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (26)
  • [36] ANALYSIS OF ERIBULIN MESYLATE UTILZATION IN PATIENTS WITH METASTATIC BREAST CANCER (MBC) BY LINE OF THERAPY AND ASSOCIATED CHANGES OVER TIME
    Feinberg, B. A.
    Drenning, J.
    Garofalo, D. F.
    Montgomery, J.
    VALUE IN HEALTH, 2015, 18 (07) : A479 - A480
  • [37] Association between bisphosphonate use in metastatic breast cancer (MBC) and overall survival
    Mathew, A.
    Rosenzweig, M. Q.
    Brufsky, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [38] Efficacy of eribulin in patients (pts) with metastatic breast cancer (MBC): a pooled analysis by HER2 and ER status
    Twelves, C.
    Cortes, J.
    Vahdat, L.
    Olivo, M.
    He, Y.
    Kaufman, P. A.
    Awada, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 261 - 262
  • [39] Practical experiences with eribulin in patients with metastatic breast cancer
    Tesch, Hans
    Schneeweiss, Andreas
    ANTI-CANCER DRUGS, 2016, 27 (02) : 112 - 117
  • [40] Case Studies in the Management of Metastatic Breast Cancer with Eribulin
    Wilks, Sharon
    McIntyre, Kristi
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2015, 9 : 81 - 85
12345